THE RESULTS OF IFN-A AS FIRST-LINE THERAPY IN PATIENTS WITH HAIRY CELL LEUKEMIA

被引：0
|
作者：
Gaman, A. M. [1 ]
Gaman, G. D. [1 ]
机构：
[1] Univ Med & Pharm Craiova, Craiova, Romania
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1561
引用
收藏
页码：604 / 604
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF INTERFERON THERAPY (IFN) ON SPLENOMEGALY IN PATIENTS WITH HAIRY-CELL LEUKEMIA
    FEDERICO, M
    CURCI, G
    PICCININI, L
    LASAGNI, D
    FRASSOLDATI, A
    BARBIERI, F
    SILINGARDI, V
    TUMORI, 1986, 72 (06) : 707 - 707
  • [2] Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia
    Chihara, Dai
    Arons, Evgeny
    Stetler-Stevenson, Maryalice
    Yuan, Constance M.
    Wang, Hao-Wei
    Zhou, Hong
    Raffeld, Mark
    Xi, Liqiang
    Steinberg, Seth M.
    Feurtado, Julie
    James, Lacey
    Wilson, Wyndham
    Braylan, Raul C.
    Calvo, Katherine R.
    Maric, Irina
    Dulau-Florea, Alina
    Kreitman, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (14) : 1527 - +
  • [3] Optimizing First-Line Therapy for Patients With Chronic Myeloid Leukemia
    Fava, Carmen
    Cortes, Jorge
    SEMINARS IN HEMATOLOGY, 2009, 46 (02) : S5 - S10
  • [4] RESULTS OF THERAPY IN HAIRY-CELL LEUKEMIA
    PRALLE, H
    LOFFLER, H
    GRAUBNER, M
    ROUX, A
    FISCHER, J
    ONKOLOGIE, 1979, 2 (02): : 87 - 90
  • [5] Cyclophosphamide as a first-line therapy in LGL leukemia
    Moignet, A.
    Hasanali, Z.
    Zambello, R.
    Pavan, L.
    Bareau, B.
    Tournilhac, O.
    Roussel, M.
    Fest, T.
    Awwad, A.
    Baab, K.
    Semenzato, G.
    Houot, R.
    Loughran, T. P., Jr.
    Lamy, T.
    LEUKEMIA, 2014, 28 (05) : 1134 - 1136
  • [6] Cyclophosphamide as a first-line therapy in LGL leukemia
    A Moignet
    Z Hasanali
    R Zambello
    L Pavan
    B Bareau
    O Tournilhac
    M Roussel
    T Fest
    A Awwad
    K Baab
    G Semenzato
    R Houot
    T P Loughran
    T Lamy
    Leukemia, 2014, 28 : 1134 - 1136
  • [7] First-Line Therapy for Chronic Lymphocytic Leukemia
    Cherng, Hua-Jay J.
    Jain, Nitin
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (04) : 725 - 738
  • [8] Phase III randomized trial of sunitinib malate (SU11248) versus interferon- alfa (IFN-A) as first-line systemic therapy for patients with metastatic renal cell carcinoma (MRCC)
    Motzer, R. J.
    Hutson, T. E.
    Tomczak, P.
    Michaelson, M. D.
    Bukowski, R. M.
    Rixe, O.
    Oudard, S.
    Kim, S. T.
    Baum, C. M.
    Figlin, R. A.
    ANNALS OF ONCOLOGY, 2006, 17 : 53 - 54
  • [9] First-line therapy of advanced chronic lymphocytic leukemia
    Wilhelm, M
    Tony, HP
    RueckleLanz, H
    Wilms, K
    LEUKEMIA, 1997, 11 : S14 - S18
  • [10] Choosing first-line therapy for chronic lymphocytic leukemia
    Jaglowski, Samantha
    Jones, Jeffrey A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (09) : 1379 - 1390
12345